Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza a(H1N1)pdm09 virus, Australia, June to August 2011

Eurosurveillance

Volumn 17, Issue 27, 2012, Pages

  Wang, B ^a   Taylor, J ^b   Ratnamohan, M ^b   McPhie, K ^b   Kesson, A ^c,d   Dixit, R ^c,d   Booy, R ^c,d   Hurt, A C ^e   Saksena, N K ^a   Dwyer, D E ^b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; SIALIDASE; VIRUS RNA;

2009 H1N1 INFLUENZA; ANTIVIRAL RESISTANCE; ARTICLE; AUSTRALIA; COMMUNITY; CONTROLLED STUDY; DISEASE TRANSMISSION; EPIDEMIC; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

EID: 84863837839     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.17.27.20210-en     Document Type: Article

References (15)

1. Lopez Chavarrias V, Broberg E, Nicoll A. Preliminary implications for Europe of the 2011 influenza season in five temperate southern hemisphere countries. Euro Surveill. 2011;16(50): pii= 20044. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20044
2. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325(5937):197-201.
3. Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 2009;83(1):90-3.
4. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301(10):1034-41.
5. Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, et al. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res. 2010;87(1):16-21.
6. Memoli MJ, Davis AS, Proudfoot K, Chertow DS, Hrabal RJ, Bristol T, et al. Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis. 2011;203(3):348-57.
7. Duan S, Boltz DA, Seiler P, Li J, Bragstad K, Nielsen LP, et al. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog. 2010;6(7):e1001022.
8. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med. 2010;362(1):86-7.
9. Hurt AC, Deng YM, Ernest J, Caldwell N, Leang L, Iannello P, et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill. 2011;16(3): pii=19770. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19770
10. Duwe SC, Wedde M, Birkner P, Schweiger B. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany. Antiviral Res. 2011;89(1):115-8.
11. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N, et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med. 2011:365(26):2541-2.
12. Kok J, Blyth CC, Foo H, Patterson J, Taylor J, McPhie K, et al. Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2. J Clin Microbiol. 2010;48(1)290-1.
13. Steain MC, Dwyer DE, Hurt AC, Kol C, Saksena NK, Cunningham AL, et al. Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification. Antiviral Res. 2009;84(3):242-8.
14. Wang B, Dwyer DE, Chew CB, Kol C, He ZP, Joshi H, et al. Sensitive detection of the K103N non-nucleoside reverse transcriptase inhibitor resistance mutation in treatment-naive HIV-1 infected individuals by rolling circle amplification. J Virol Methods. 2009;161(1):128-35.
15. Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science. 2010;328(5983):1272-5.